Another treatment possibility for nmCRPC.
FDA approves darolutamide for non-met... - Advanced Prostate...
FDA approves darolutamide for non-metastatic castration-resistant prostate cancer
Written by
tango65
To view profiles and participate in discussions please or .
5 Replies
•
Erleada.
Zytiga, Xtandi, Erleada. I guess the next one will be called Ozmundi?
Now I just hope they come up with something new soon for mCRPC.
Not what you're looking for?
You may also like...
FDA Approves Darolutamide Plus Docetaxel for Metastatic Hormone-Sensitive Prostate Cancer
onclive.com/view/fda-and-ema-approval-sought-for-darolutamide-plus-docetaxel-in-metastatic-hormone-s
FDA Approves First PARP Inhibitor Rucaparib for BRCA-mutated metastatic castration-resistant prostate cancer
https://www.fda.gov/drugs/fda-grants-accelerated-approval-rucaparib-brca-mutated-metastatic-castrati
Can darolutamide be prescribed to metastatic, castrate-resistant PC
it is not for metastatic PC. I noticed that the FDA approved darolutamide for metastatic,...
Apalutamide for Metastatic Castration-Sensitive Prostate Cancer
assigned 525 patients with metastatic, castration-sensitive prostate cancer to receive apalutamide...
Treatment After Progression in Metastatic Castration-Resistant Prostate Cancer: some options
n-in-metastatic-castration-resistant-prostate-cancer